{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T03:20:32Z","timestamp":1787541632248,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10620-026-09813-w","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:59:08Z","timestamp":1773759548000},"page":"3539-3548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CircRSF1 Promoted HepG2 Cell Proliferation, Migration and Invasion Depending on EIF4A3"],"prefix":"10.1007","volume":"71","author":[{"given":"Dan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"9813_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301\u20131314.","journal-title":"Lancet."},{"key":"9813_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cld.2022.08.004","volume":"27","author":"P Ganesan","year":"2023","unstructured":"Ganesan P, Kulik LM. Hepatocellular carcinoma: new developments. Clin Liver Dis. 2023;27:85\u2013102.","journal-title":"Clin Liver Dis."},{"key":"9813_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2174\/1874467213666200224102820","volume":"13","author":"M Wu","year":"2020","unstructured":"Wu M, Miao H, Fu R, Zhang J, Zheng W. Hepatic stellate cell: a potential target for hepatocellular carcinoma. Curr Mol Pharmacol. 2020;13:261\u2013272.","journal-title":"Curr Mol Pharmacol."},{"key":"9813_CR4","doi-asserted-by":"publisher","first-page":"e18761429310703","DOI":"10.2174\/0118761429310703240823045808","volume":"17","author":"B Sensi","year":"2024","unstructured":"Sensi B, Angelico R, Toti L, Conte L, Coppola A, Tisone G et al. Mechanism, potential, and concerns of immunotherapy for hepatocellular carcinoma and liver transplantation. Curr Mol Pharmacol. 2024;17:e18761429310703.","journal-title":"Curr Mol Pharmacol."},{"key":"9813_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41392-020-00453-8","volume":"6","author":"Q Li","year":"2021","unstructured":"Li Q, Ni Y, Zhang L, Jiang R, Xu J, Yang H et al. HIF-1alpha-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation. Signal Transduct Target Ther. 2021;6:76.","journal-title":"Signal Transduct Target Ther."},{"key":"9813_CR6","doi-asserted-by":"publisher","first-page":"175883592110423","DOI":"10.1177\/17588359211042304","volume":"13","author":"H Xu","year":"2021","unstructured":"Xu H, Schmidt R, Hamm CA, Schobert IT, He Y, Boning G et al. Comparison of intrahepatic progression patterns of hepatocellular carcinoma and colorectal liver metastases following CT-guided high dose-rate brachytherapy. Ther Adv Med Oncol. 2021;13:17588359211042304.","journal-title":"Ther Adv Med Oncol."},{"key":"9813_CR7","doi-asserted-by":"publisher","first-page":"599124","DOI":"10.3389\/fonc.2021.599124","volume":"11","author":"W Zhu","year":"2021","unstructured":"Zhu W, Li J, Zhang Y, Zhu Z, Liu H, Lin Y et al. Inhibition of HMGB1 suppresses hepatocellular carcinoma progression via HIPK2-mediated autophagic degradation of ZEB1. Front Oncol. 2021;11:599124.","journal-title":"Front Oncol."},{"key":"9813_CR8","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.trecan.2021.01.012","volume":"7","author":"V Leone","year":"2021","unstructured":"Leone V, Ali A, Weber A, Tschaharganeh DF, Heikenwalder M. Liver inflammation and hepatobiliary cancers. Trends Cancer. 2021;7:606\u2013623.","journal-title":"Trends Cancer."},{"key":"9813_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41598-019-57285-y","volume":"10","author":"R Li","year":"2020","unstructured":"Li R, Ong SL, Tran LM, Jing Z, Liu B, Park SJ et al. Chronic IL-1beta-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer. Sci Rep. 2020;10:377.","journal-title":"Sci Rep."},{"key":"9813_CR10","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","volume":"390","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Macfadyen JG, Thuren T, Everett BM, Libby P, Glynn RJ et al. Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet. 2017;390:1833\u20131842.","journal-title":"Lancet."},{"key":"9813_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12943-019-1082-3","volume":"18","author":"J Hou","year":"2019","unstructured":"Hou J, Zhang H, Liu J, Zhao Z, Wang J, Lu Z et al. YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma. Mol Cancer. 2019;18:163.","journal-title":"Mol Cancer."},{"key":"9813_CR12","doi-asserted-by":"publisher","first-page":"4936","DOI":"10.1080\/21655979.2021.1960769","volume":"12","author":"G Yuan","year":"2021","unstructured":"Yuan G, Ding W, Sun B, Zhu L, Gao Y, Chen L. Upregulated circRNA_102231 promotes gastric cancer progression and its clinical significance. Bioengineered. 2021;12:4936\u20134945.","journal-title":"Bioengineered."},{"key":"9813_CR13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/15384047.2020.1776075","volume":"21","author":"J Zhang","year":"2020","unstructured":"Zhang J, Wang H, Wu K, Zhan F, Zeng H. Dysregulated circRNA_100876 contributes to proliferation and metastasis of colorectal cancer by targeting microRNA-516b (miR-516b). Cancer Biol Ther. 2020;21:733\u2013740.","journal-title":"Cancer Biol Ther."},{"key":"9813_CR14","doi-asserted-by":"publisher","first-page":"639963","DOI":"10.3389\/fphar.2021.639963","volume":"12","author":"R Liu","year":"2021","unstructured":"Liu R, Li Y, Wu A, Kong M, Ding W, Hu Z et al. Identification of plasma hsa_circ_0005397 and combined with serum AFP, AFP-L3 as potential biomarkers for hepatocellular carcinoma. Front Pharmacol. 2021;12:639963.","journal-title":"Front Pharmacol."},{"key":"9813_CR15","doi-asserted-by":"publisher","first-page":"110887","DOI":"10.1016\/j.intimp.2023.110887","volume":"124","author":"J Zang","year":"2023","unstructured":"Zang J, Xiao L, Shi X, Liu S, Wang Y, Sun B et al. Hsa_circ_0001479 accelerates tumorigenesis of gastric cancer and mediates immune escape. Int Immunopharmacol. 2023;124:110887.","journal-title":"Int Immunopharmacol."},{"key":"9813_CR16","doi-asserted-by":"publisher","first-page":"8839","DOI":"10.1007\/s00210-024-03175-8","volume":"397","author":"Q Ma","year":"2024","unstructured":"Ma Q, Yu W, Li Z, Zhang X, Zhang L. Circ_0081723 enhances cervical cancer progression and modulates CREBRF via sponging miR-545-3p. Naunyn Schmiedebergs Arch Pharmacol. 2024;397:8839\u20138852.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"9813_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/15476286.2015.1020271","volume":"12","author":"LL Chen","year":"2015","unstructured":"Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12:381\u2013388.","journal-title":"RNA Biol."},{"key":"9813_CR18","doi-asserted-by":"publisher","first-page":"e170223213775","DOI":"10.2174\/1874467216666230217151946","volume":"17","author":"Q Zeng","year":"2024","unstructured":"Zeng Q, Feng K, Yu Y, Lv Y. Hsa_Circ_0000021 sponges miR-3940-3p\/KPNA2 expression to promote cervical cancer progression. Curr Mol Pharmacol. 2024;17:e170223213775.","journal-title":"Curr Mol Pharmacol."},{"key":"9813_CR19","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.biopsych.2020.02.018","volume":"88","author":"R Huang","year":"2020","unstructured":"Huang R, Zhang Y, Bai Y, Han B, Ju M, Chen B et al. N(6)-methyladenosine modification of fatty acid amide hydrolase messenger RNA in circular RNA STAG1-regulated astrocyte dysfunction and depressive-like behaviors. Biol Psychiatry. 2020;88:392\u2013404.","journal-title":"Biol Psychiatry."},{"key":"9813_CR20","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1080\/15548627.2017.1356975","volume":"13","author":"R Huang","year":"2017","unstructured":"Huang R, Zhang Y, Han B, Bai Y, Zhou R, Gan G et al. Circular RNA HIPK2 regulates astrocyte activation via cooperation of autophagy and ER stress by targeting MIR124-2HG. Autophagy. 2017;13:1722\u20131741.","journal-title":"Autophagy."},{"key":"9813_CR21","doi-asserted-by":"publisher","first-page":"e70205","DOI":"10.1002\/jbt.70205","volume":"39","author":"D Yin","year":"2025","unstructured":"Yin D, Yang L, Chen Y. Circ_0022587 regulates tumor properties of human breast cancer cells by targeting miR-335-5p\/phosphoglycerate kinase 1 pathway. J Biochem Mol Toxicol. 2025;39:e70205.","journal-title":"J Biochem Mol Toxicol."},{"key":"9813_CR22","doi-asserted-by":"publisher","first-page":"107127","DOI":"10.1016\/j.phrs.2024.107127","volume":"202","author":"Z Tang","year":"2024","unstructured":"Tang Z, Li J, Lu B, Zhang X, Yang L, Qi Y et al. CircBIRC6 facilitates the malignant progression via miR-488\/GRIN2D-mediated CAV1-autophagy signal axis in gastric cancer. Pharmacol Res. 2024;202:107127.","journal-title":"Pharmacol Res."},{"key":"9813_CR23","doi-asserted-by":"publisher","first-page":"8270","DOI":"10.1002\/jcp.29483","volume":"235","author":"Y Chen","year":"2020","unstructured":"Chen Y, Yuan B, Chen G, Zhang L, Zhuang Y, Niu H et al. Circular RNA RSF1 promotes inflammatory and fibrotic phenotypes of irradiated hepatic stellate cell by modulating miR-146a-5p. J Cell Physiol. 2020;235:8270\u20138282.","journal-title":"J Cell Physiol."},{"key":"9813_CR24","first-page":"46","volume":"43","author":"P Zhou","year":"2023","unstructured":"Zhou P, Cheng B, Sun Y, Wu D, Chen Y. Circular RNA circRSF1 binds to HuR to promote radiation-induced inflammatory phenotype in hepatic stellate cells. Nan Fang Yi Ke Da Xue Xue Bao. 2023;43:46\u201351.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao."},{"key":"9813_CR25","doi-asserted-by":"publisher","first-page":"1382029","DOI":"10.3389\/fcimb.2024.1382029","volume":"14","author":"P Wan","year":"2024","unstructured":"Wan P, Yang G, Cheng Q, Zhang X, Yue Z, Li M et al. The role of inflammasome in chronic viral hepatitis. Front Cell Infect Microbiol. 2024;14:1382029.","journal-title":"Front Cell Infect Microbiol."},{"key":"9813_CR26","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.3748\/wjg.v27.i24.3466","volume":"27","author":"A Perisetti","year":"2021","unstructured":"Perisetti A, Goyal H, Yendala R, Thandassery RB, Giorgakis E. Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: current insights and advancements. World J Gastroenterol. 2021;27:3466\u20133482.","journal-title":"World J Gastroenterol."},{"key":"9813_CR27","doi-asserted-by":"publisher","first-page":"102000","DOI":"10.1016\/j.xcrm.2025.102000","volume":"6","author":"S Yang","year":"2025","unstructured":"Yang S, Qiu X, Yang Y, Wu J, Wang S, Zheng B et al. LTA4H improves the tumor microenvironment and prevents HCC progression via targeting the HNRNPA1\/LTBP1\/TGF-beta axis. Cell Rep Med. 2025;6:102000.","journal-title":"Cell Rep Med."},{"key":"9813_CR28","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/ijms24010437","volume":"24","author":"A Khanam","year":"2022","unstructured":"Khanam A, Kottilil S. New therapeutics for HCC: does tumor immune microenvironment matter? Int J Mol Sci. 2022;24:437.","journal-title":"Int J Mol Sci."},{"key":"9813_CR29","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41419-020-03276-1","volume":"11","author":"G Huang","year":"2020","unstructured":"Huang G, Liang M, Liu H, Huang J, Li P, Wang C et al. CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p\/RTKN2 axis and activating Wnt\/beta-catenin pathway. Cell Death Dis. 2020;11:1065.","journal-title":"Cell Death Dis."},{"key":"9813_CR30","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1158\/0008-5472.CAN-21-1259","volume":"82","author":"J Li","year":"2022","unstructured":"Li J, Hu ZQ, Yu SY, Mao L, Zhou ZJ, Wang PC et al. CircRPN2 inhibits aerobic glycolysis and metastasis in hepatocellular carcinoma. Cancer Res. 2022;82:1055\u20131069.","journal-title":"Cancer Res."},{"key":"9813_CR31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41467-024-55577-0","volume":"16","author":"T Lan","year":"2025","unstructured":"Lan T, Gao F, Cai Y, Lv Y, Zhu J, Liu H et al. The protein circPETH-147aa regulates metabolic reprogramming in hepatocellular carcinoma cells to remodel immunosuppressive microenvironment. Nat Commun. 2025;16:333.","journal-title":"Nat Commun."},{"key":"9813_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13045-023-01452-2","volume":"16","author":"F Zhang","year":"2023","unstructured":"Zhang F, Jiang J, Qian H, Yan Y, Xu W. Exosomal circRNA: emerging insights into cancer progression and clinical application potential. J Hematol Oncol. 2023;16:67.","journal-title":"J Hematol Oncol."},{"key":"9813_CR33","doi-asserted-by":"publisher","first-page":"216957","DOI":"10.1016\/j.canlet.2024.216957","volume":"593","author":"J Lun","year":"2024","unstructured":"Lun J, Zhang Y, Yu M, Zhai W, Zhu L, Liu H et al. Circular RNA circHIPK2 inhibits colon cancer cells through miR-373-3p\/RGMA axis. Cancer Lett. 2024;593:216957.","journal-title":"Cancer Lett."},{"key":"9813_CR34","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.18632\/aging.202470","volume":"13","author":"J Liu","year":"2021","unstructured":"Liu J, Zhang J, Zhang G, Zhou T, Zou X, Guan H et al. CircMRE11A_013 binds to UBXN1 and integrates ATM activation enhancing lens epithelial cells senescence in age-related cataract. Aging (Albany NY). 2021;13:5383\u20135402.","journal-title":"Aging (Albany NY)."},{"key":"9813_CR35","doi-asserted-by":"publisher","first-page":"109907","DOI":"10.1016\/j.intimp.2023.109907","volume":"117","author":"R Huang","year":"2023","unstructured":"Huang R, Cai L, Ma X, Shen K. Autophagy-mediated circHIPK2 promotes lipopolysaccharide-induced astrocytic inflammation via SIGMAR1. Int Immunopharmacol. 2023;117:109907.","journal-title":"Int Immunopharmacol."},{"key":"9813_CR36","doi-asserted-by":"publisher","first-page":"578265","DOI":"10.1016\/j.jneuroim.2023.578265","volume":"387","author":"R Huang","year":"2024","unstructured":"Huang R, Sun M, Wang W, Yu X, Liu F. YTHDF2 alleviates microglia activation via promoting circHIPK2 degradation. J Neuroimmunol. 2024;387:578265.","journal-title":"J Neuroimmunol."},{"key":"9813_CR37","doi-asserted-by":"publisher","first-page":"6849","DOI":"10.1093\/nar\/gkab523","volume":"49","author":"D Knupp","year":"2021","unstructured":"Knupp D, Cooper DA, Saito Y, Darnell RB, Miura P. NOVA2 regulates neural circRNA biogenesis. Nucleic Acids Res. 2021;49:6849\u20136862.","journal-title":"Nucleic Acids Res."},{"key":"9813_CR38","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1261\/rna.079318.122","volume":"29","author":"SK Naineni","year":"2023","unstructured":"Naineni SK, Cencic R, Robert F, Brown LE, Haque M, Scott-Talib J et al. Exploring the targeting spectrum of rocaglates among eIF4A homologs. RNA. 2023;29:826\u2013835.","journal-title":"RNA."},{"key":"9813_CR39","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13046-024-03116-6","volume":"43","author":"L Li","year":"2024","unstructured":"Li L, Liu D, Chen T, Wei C, Qiao Y, Liu W et al. Hypoxia-enhanced YAP1-EIF4A3 interaction drives circ_0007386 circularization by competing with CRIM1 pre-mRNA linear splicing and promotes non-small cell lung cancer progression. J Exp Clin Cancer Res. 2024;43:200.","journal-title":"J Exp Clin Cancer Res."},{"key":"9813_CR40","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1002\/tox.24171","volume":"39","author":"B Zheng","year":"2024","unstructured":"Zheng B, Zhou B, Ye D, Wang Y, Zheng W, Wang X et al. LINC01572 promotes triple-negative breast cancer progression through EIF4A3-mediated beta-catenin mRNA nuclear exportation. Environ Toxicol. 2024;39:3026\u20133039.","journal-title":"Environ Toxicol."},{"key":"9813_CR41","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.omtn.2019.10.043","volume":"19","author":"W Tang","year":"2020","unstructured":"Tang W, Wang D, Shao L, Liu X, Zheng J, Xue Y et al. LINC00680 and TTN-AS1 stabilized by EIF4A3 promoted malignant biological behaviors of glioblastoma cells. Mol Ther Nucleic Acids. 2020;19:905\u2013921.","journal-title":"Mol Ther Nucleic Acids."},{"key":"9813_CR42","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/1759-7714.14762","volume":"14","author":"Q Xu","year":"2023","unstructured":"Xu Q, Zhao T, Han H, Fan J, Xie W. EIF4A3 stabilizes the expression of lncRNA AGAP2-AS1 to activate cancer-associated fibroblasts via MyD88\/NF-kappab signaling. Thorac Cancer. 2023;14:450\u2013461.","journal-title":"Thorac Cancer."},{"key":"9813_CR43","doi-asserted-by":"publisher","first-page":"19979","DOI":"10.1038\/s41598-025-86048-1","volume":"15","author":"G Cheng","year":"2025","unstructured":"Cheng G, Yang X, Tang Y, Wu C, Tang Z, Wei S. EIF4A3 enhances the viability, invasion and osteogenic differentiation of BMSCs via the USP53\/SMAD5 pathway. Sci Rep. 2025;15:19979.","journal-title":"Sci Rep."},{"key":"9813_CR44","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1126\/science.abj9090","volume":"379","author":"PC He","year":"2023","unstructured":"He PC, Wei J, Dou X, Harada BT, Zhang Z, Ge R et al. Exon architecture controls mRNA m(6)A suppression and gene expression. Science. 2023;379:677\u2013682.","journal-title":"Science."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09813-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-09813-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09813-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T03:01:40Z","timestamp":1787540500000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-09813-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["9813"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-09813-w","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Before hospitalization and surgery, written informed consent was acquired from all patients.","order":2,"name":"Ethics","label":"Patient consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}